Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$237,399,944
+$30,625,459 QoQ
Shares Held
943,411
-0.8% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#139
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STATE OF WISCONSIN INVESTMENT BOARD holds $1,684,684,392 across 11 Drug Manufacturers - General names. ABBV ranks #3 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
428,209 | $513,606,763 | |
| 2 | JNJ |
Johnson & Johnson
|
1,284,259 | $326,163,258 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
943,411 | $237,399,944 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,318,963 | $169,486,745 | |
| 5 | AMGN |
Amgen Inc
|
287,659 | $104,167,077 | |
| 6 | AZN |
Astrazeneca PLC
|
475,058 | $90,080,497 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
662,319 | $83,677,382 | |
| 8 | PFE |
Pfizer Inc
|
3,035,990 | $73,106,639 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $237,399,944 | 943,411 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $206,774,485 | 950,731 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $210,078,961 | 919,423 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $216,499,624 | 935,042 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $178,876,425 | 963,670 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $213,963,500 | 1,021,208 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $178,250,514 | 1,003,098 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $208,335,278 | 1,054,969 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $172,643,456 | 1,006,550 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $189,030,726 | 1,038,060 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $150,531,659 | 971,360 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $142,583,641 | 956,552 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $131,768,365 | 978,018 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $158,764,553 | 996,201 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $145,750,079 | 901,863 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $134,753,013 | 1,004,046 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $191,863,532 | 1,252,700 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $216,677,360 | 1,336,607 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $188,815,300 | 1,394,500 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $124,537,425 | 1,154,514 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $196,863,068 | 1,747,719 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $198,002,017 | 1,829,625 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $186,664,300 | 1,742,084 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $161,374,502 | 1,842,385 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $197,475,422 | 2,011,361 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $113,813,307 | 1,493,809 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||